Home » Topics » Regulatory

Regulatory
RSS

FDA approves Orkambi for younger cystic fibrosis population

Sep. 29, 2016

FDA approves Rexulti labeling update for maintenance treatment of schizophrenia

Sep. 26, 2016

FDA approves adalimumab biosimilar Amjevita

Sep. 26, 2016

FDA grants accelerated approval to Exondys 51 for Duchenne muscular dystrophy

Sep. 20, 2016

FDA approves Aralez Pharmaceuticals' Yosprala

Sep. 16, 2016

Opdivo intravenous infusion approved in Japan for treatment of unresectable or metastatic RCC

Sep. 8, 2016

FDA approves Blincyto for pediatric patients with Ph-negative B-cell precursor ALL

Sep. 2, 2016

European Commission approves Pfizer's crizotinib for ROS-1 positive NSCLC

Sep. 1, 2016

FDA approves biosimilar etanercept Erelzi

Aug. 31, 2016

Hemispherx Biopharma's NDA for rintatolimod receives approval in Argentina

Aug. 24, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...